| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/20/2006 | EP1732500A2 Cosmetic composition and method for retarding hair growth |
| 12/20/2006 | EP1732486A1 Drug-enhanced adhesion prevention |
| 12/20/2006 | EP1732387A2 Stable, neutral ph, voc-free biocidal compositions of 1,2-benzisothiazolin-3-one |
| 12/20/2006 | EP1732384A1 Novel synthetic c-glycolipids, their synthesis and use to treat infections, cancer and autoimmune diseases |
| 12/20/2006 | EP1670458B1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics |
| 12/20/2006 | EP1660687A4 Rnai-based modification of heterochromatin |
| 12/20/2006 | EP1651220B1 2-[4- (2-hydroxymethyl-phenylamino)-piperidin-1-yl] - n-(9h-carbazol-3-yl) - acetamide derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity |
| 12/20/2006 | EP1648458B1 2-[4(phenylamino)-piperidin-1-yl]-n-phenyl-acetamide derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity |
| 12/20/2006 | EP1641471B1 Biocompatible polymer networks |
| 12/20/2006 | EP1631557B1 Cyclic hydroxylamine as psychoactive compounds |
| 12/20/2006 | EP1628989B1 Novel 14 and 15 membered-ring compounds |
| 12/20/2006 | EP1622610B1 1-(2h-pyrazol-3-yl)-3-{4-[1-(benzoyl)-piperidin-4-ylmethyl]-phenyl}-urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations |
| 12/20/2006 | EP1562617B1 New use of pipataline |
| 12/20/2006 | EP1551822B1 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
| 12/20/2006 | EP1542977B1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 12/20/2006 | EP1539164B1 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
| 12/20/2006 | EP1523335B1 Injectable depot formulation comprising crystals of iloperidone |
| 12/20/2006 | EP1511732B1 Process for the manufacture of quinoline derivatives |
| 12/20/2006 | EP1509501B1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 12/20/2006 | EP1509285B1 Synergistic composition of trans-tetracos-15-enoic acid and apocynin and use thereof |
| 12/20/2006 | EP1506200B1 Diazabicyclic biaryl derivatives |
| 12/20/2006 | EP1474152B1 Orodispersible pharmaceutical composition comprising ivabradine |
| 12/20/2006 | EP1461308B1 Bacterial enzyme inhibitors |
| 12/20/2006 | EP1456171B1 Substituted cyclohexane derivatives |
| 12/20/2006 | EP1441726B1 Derivatives of phenoxy-n-'4-(isothiazolidin-1,1-dioxid-2yl)pheny]-valerian- acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumors |
| 12/20/2006 | EP1438310B1 Beta-carbolin derivatives as ptp-inhibitors |
| 12/20/2006 | EP1434762B1 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 12/20/2006 | EP1401809B1 Tryptase inhibitors |
| 12/20/2006 | EP1392314B1 NOVEL USE OF 2-[2-Ethoxy-5-(4-methyl-piperazin-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-on |
| 12/20/2006 | EP1390362B1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 12/20/2006 | EP1379235B1 Compositions and methods for enhancing paracellular permeability across epithelial and endothelial barriers |
| 12/20/2006 | EP1372665B1 Hormone replacement therapy method and its administration form |
| 12/20/2006 | EP1357935B1 Reducing side effects of chemotherapy in cancer patients |
| 12/20/2006 | EP1357903B1 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4- 2-(PIPERIDIN-1-YL) ETHOXY|PHENOXY)-2-(4-METHOXYPHENYL) BENZO b|THIOPHENE AND SALTS THEREOF |
| 12/20/2006 | EP1353696B1 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 12/20/2006 | EP1343473B1 Pharmaceutical dronedarone composition for parenteral administration |
| 12/20/2006 | EP1311279B1 Treatment of hepatitis c with thymosin, interferon and ribavirin |
| 12/20/2006 | EP1305308B1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 12/20/2006 | EP1276720B1 2-acyl indol derivatives and their use as anti-tumour agents |
| 12/20/2006 | EP1276472B1 Formulations for use in inhaler devices |
| 12/20/2006 | EP1272457B9 Compounds for modulating cell proliferation |
| 12/20/2006 | EP1263729B1 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 12/20/2006 | EP1256344B1 Remedies for endothelin-induced diseases |
| 12/20/2006 | EP1235835B1 Chromium-histidine complexes as nutrient supplements |
| 12/20/2006 | EP1202967B1 Sulfuric acid mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester |
| 12/20/2006 | EP1187816B1 5-cyano-2-aminopyrimidine derivatives |
| 12/20/2006 | EP1172107B1 Drugs containing sulfopyranosylacylglycerol derivatives |
| 12/20/2006 | EP1147111B1 Cryptate compounds and methods for diagnosis and therapy |
| 12/20/2006 | EP1131294B1 Quinoline derivatives as nk-2 and nk-3 receptor ligands |
| 12/20/2006 | EP1124531B1 Reduction of hair growth |
| 12/20/2006 | EP1121103B1 Orally disintegrable tablets comprising a benzimidazole |
| 12/20/2006 | EP1068219B1 Acylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| 12/20/2006 | EP1023075B1 Liquid presentations of oxazaphosphorine-containing pharmaceutical products |
| 12/20/2006 | EP0966442B1 Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity |
| 12/20/2006 | EP0858336B1 Method and pharmaceutical composition for regulating lipid concentration |
| 12/20/2006 | EP0836476B1 A COSMETIC COMPOSITION comprising the glycopropyl ester of retinoic acid FOR SKIN APPLICATIONS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF skin diseases, TUMOROUS CELLS, BLADDER OR NERVE DISORDERS |
| 12/20/2006 | EP0764022B1 Agonists and antagonists of the nicotinic acetylcholine receptors of insects to control endoparasites |
| 12/20/2006 | CN1882693A Polyethyleneglycol-modified lipid compounds and uses thereof |
| 12/20/2006 | CN1882687A Method of growing myocardial cells |
| 12/20/2006 | CN1882612A Hypo- and hyper-acetylated meningococcal capsular saccharides |
| 12/20/2006 | CN1882606A 雌激素受体调节剂 Estrogen receptor modulators |
| 12/20/2006 | CN1882602A The moduilation of hyaluronan synthesis and degradation in the treatment of disease |
| 12/20/2006 | CN1882598A Phosphinic acid derivatives |
| 12/20/2006 | CN1882594A Particle-forming compositions containing fused pyrrolocarbazoles |
| 12/20/2006 | CN1882593A Fused pentacyclic polyethers |
| 12/20/2006 | CN1882591A 5,7-diaminopyrazolo '4,3-d!pyrimidines with pde-5 inhibiting activity |
| 12/20/2006 | CN1882590A Fused heterocyclic compounds as serotonin receptor modulators |
| 12/20/2006 | CN1882587A Use of tricyclic compounds as glycine transport inhibitors |
| 12/20/2006 | CN1882586A 1H-imidazo[4,5-C]quinoline derivatives in the treatment of protein kinase dependent diseases |
| 12/20/2006 | CN1882585A Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
| 12/20/2006 | CN1882584A 4-substituted imidazoles |
| 12/20/2006 | CN1882583A 5-substituted imidazoles |
| 12/20/2006 | CN1882582A Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same |
| 12/20/2006 | CN1882580A Quinazoline derivatives as antiproliferative agents |
| 12/20/2006 | CN1882579A Substituted heteroaryl benzofuran acids |
| 12/20/2006 | CN1882578A 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors |
| 12/20/2006 | CN1882577A 喹唑啉衍生物 Quinazoline derivatives |
| 12/20/2006 | CN1882576A 喹唑啉衍生物 Quinazoline derivatives |
| 12/20/2006 | CN1882575A Substituted pyrrole-indoles as inhibitors of PAI-1 |
| 12/20/2006 | CN1882574A Pyrazolyl and imidazolyl pyrimidines |
| 12/20/2006 | CN1882573A Quinazoline derivatives as tyrosine kinase inhibitors |
| 12/20/2006 | CN1882572A Quinazoline derivatives as antitumor agents |
| 12/20/2006 | CN1882570A 喹唑啉衍生物 Quinazoline derivatives |
| 12/20/2006 | CN1882569A 喹唑啉衍生物 Quinazoline derivatives |
| 12/20/2006 | CN1882568A Pyrrol derivatives with antibacterial activity |
| 12/20/2006 | CN1882567A Quinazoline derivatives as tyrosine kinase inhibitors |
| 12/20/2006 | CN1882566A Crystalline forms of (+)- and (-)-erythro-mefloquine hydrochloride |
| 12/20/2006 | CN1882565A Novel piperidine-substituted indoles-or hetero-derivatives thereof and their use as modulators of chemokine receptor (CCR-3) |
| 12/20/2006 | CN1882564A Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1) |
| 12/20/2006 | CN1882563A Antidiabetic compounds comprising benzofuran and benzothiophene derivatives |
| 12/20/2006 | CN1882560A Heterocompound and its production and usage method |
| 12/20/2006 | CN1882557A 4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof |
| 12/20/2006 | CN1882556A Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 12/20/2006 | CN1882555A 5-(benz- (z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents |
| 12/20/2006 | CN1882554A Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 12/20/2006 | CN1882553A Phenylacetic acid derivative, process for producing the same, and use |
| 12/20/2006 | CN1882551A Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 12/20/2006 | CN1882549A 7-phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 12/20/2006 | CN1882548A pH sensitive prodrugs of 2,6-diisopropylphenol |
| 12/20/2006 | CN1882547A 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |